Tuberculosis: pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice (Small 38/2015)
Source abstract
Abstract
On page 5066, J. I. Zink, M. A. Horwitz, and co-workers use confocal microscopy to demonstrate the avid uptake of RITC-labeled mesoporous silica nanoparticles loaded with the anti-tuberculosis drug isoniazid (shown here in red) by human macrophages (nuclei stained blue with DAPI) infected with GFP-expressing Mycobacterium tuberculosis (shown here in green).
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Tuberculosis Research and Epidemiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Biochemistry University of California Los Angeles 3013 Young Dr. East CA 90095‐1569 USA
Division of Infectious Diseases Department of Medicine University of California Los Angeles CHS 37‐121, 10833 Le Conte Ave. CA 90095‐1688 USA
California NanoSystems Institute University of California Los Angeles CA 90095‐8352 USA
References
Reference metadata was not supplied for this record.